U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (PF-06804103)Cat. No. WA1636Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (PF-06804103)Cat. No. WA1636
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (ONS-1050)Cat. No. WA1635
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (NM-02)Cat. No. WA1634
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (NJH395)Cat. No. WA1633
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (NeuCeptin)Cat. No. WA1632
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (MI130004)Cat. No. WA1631
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (MEDI4276)Cat. No. WA1630
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (m860)Cat. No. WA1629
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (LZM-005)Cat. No. WA1628
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (LCB14-0110)Cat. No. WA1627
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (KL-A166)Cat. No. WA1626
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (JHL1199)Cat. No. WA1625